# Kaipharm Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kaipharm-co

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.kaipharm.com
- Total disclosed funding: $4.3M
- Latest round: Series A (Jan 23, 2020)
- Investors on record: 7

## About

Based in Seoul, South Korea, and founded in 2018 by CEO Wankyu Kim, Kaipharm Co. Ltd., a.k.a. Kaipharm is an AI (artificial intelligence)-driven drug discovery company that builds a database of compound structures, drug-disease relationships, drug-target relationships, drug-induced transcriptome, and data mining technologies for developing artificial intelligence (AI) algorithms and providing complex solutions. In February 2020, Kaipharm Co. Ltd. raised USD 4.2 million in a Series A funding.

The company provides a drug-induced transcriptome platform that offers information on drug mode-of-action (MoA), reflecting genome-wide perturbation on gene expression by drug treatment for targets and unknown off-targets. Kaipharm also offers KMAP, an integrated platform for analyzing drug-induced transcriptome data that enables MoA analysis and identification of novel indications for a given drug. In addition, the firm performs large-scale mining for drug screening and bioassay datasets. The company has developed multiple virtual screening technologies, such as BEAR (bioactive compound enrichment by assay repositioning) registered in US and Korea, and BACoN registered in Korea patents for drug virtual screening services.

## Funding rounds

- Series A, Jan 23, 2020, $4.3M — Innopolis Partners, KB Investment, Kolon Investment, P&I Investment, E&Venture Partners, Ulmus Investment, Kingo Investment Partners

## Investors

- Innopolis Partners (https://capitalatlas.ai/funds/innopolis-partners) — Series A
- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series A
- Kolon Investment (https://capitalatlas.ai/funds/kolon-investment) — Series A
- P&I Investment (https://capitalatlas.ai/funds/p-i-investment) — Series A
- E&Venture Partners (https://capitalatlas.ai/funds/e-venture-partners) — Series A
- Ulmus Investment (https://capitalatlas.ai/funds/ulmus-investment) — Series A
- Kingo Investment Partners (https://capitalatlas.ai/funds/kingo-investment-partners) — Series A